Reven Pharmaceuticals' Debt Round

Reven Pharmaceuticals raised a round of funding on January 30, 2014.

Reven Pharmaceuticals is a development-stage healthcare company that is in the process of requesting FDA 'fast track' status for its proprietary treatment of Critical Limb Ischemia. The treatments are…

Articles about Reven Pharmaceuticals' Debt Round: